edoc

Efavirenz in an obese HIV-infected patient - a report and an in vitro-in vivo extrapolation model indicate risk of underdosing

de Roche, Mirjam and Siccardi, Marco and Stoeckle, Marcel and Livio, Françoise and Back, David and Battegay, Manuel and Marzolini, Catia. (2012) Efavirenz in an obese HIV-infected patient - a report and an in vitro-in vivo extrapolation model indicate risk of underdosing. Antiviral Therapy, 17 (7). pp. 1381-1384.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/69522/

Downloads: Statistics Overview

Abstract

Here, we report suboptimal efavirenz exposure in an obese patient treated with the standard 600 mg dose. Tripling the dose allowed attainment of therapeutic efavirenz concentrations. We developed an in vitro-in vivo extrapolation model to quantify dose requirements in obese individuals. Obesity represents a risk factor for antiretroviral therapy underdosing.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Infektiologie > Infektiologie (Battegay M)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Infektiologie > Infektiologie (Battegay M)
UniBasel Contributors:Marzolini, Catia
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
Publisher:International Medical Press
ISSN:1359-6535
e-ISSN:2040-2058
Note:Publication type according to Uni Basel Research Database: Journal item
Related URLs:
Identification Number:
Last Modified:08 Jul 2020 06:53
Deposited On:01 Jul 2020 12:50

Repository Staff Only: item control page